Searchable abstracts of presentations at key conferences in endocrinology

ea0026p576 | Cardiovascular endocrinology and lipid metabolism | ECE2011

Parathormone 1-84 in type 2 diabetic patients

Belovici M I , Buysschaert M

Objective: Increasing evidence suggests a role for mineral metabolism in cardio-vascular disease risk. We aimed at determining in type 2 diabetes patients the relationship between serum levels of 1–84 parathormone (PTH1–84), 25-hydroxy-vitamin D (25(OH)D) or calcium and the glycated hemoglobin (HbA1c), insulin sensitivity or β-cells function, but also the relationship between these factors and coronary arterial disease confirmed by myocardial scintigraphy.<p...

ea0026p702 | Diabetes complications | ECE2011

Matrix γ-carboxyglutamate (Gla) protein (MGP) in type 2 diabetes

Belovici M I , Buysschaert M

Objective: Matrix γ-carboxyglutamate (Gla) protein (MGP) is a marker of athero-sclerosis reflecting the degree of inhibition of ongoing calcification processes in the vascular wall. Osteoprotegerin (OPG) and adiponectin (ADP) exerts anti-inflammatory and anti-atherosclerotic effects. We aimed at determining in type 2 diabetes patients the relationship between serum MGP, OPG, ADP levels and the HbA1c, HOMA insulin-sensitivity or B-cell function.Resea...